Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Millennium Cancer Center offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2004, the accredited hospital is located in Gurgaon, India, with 100 beds, providing comprehensive care for local and international patients.
Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.
At Carolina Medical Center, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1998, the ISO accredited hospital is located in Warsaw, Poland, and has 60 beds.
Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.
Delhi, India
Max Super Speciality Hospital, Patparganj offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2005, the NABH, NABL, AACI accredited hospital is located in Delhi, India, with 400 beds, providing comprehensive care for local and international patients.
Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.
Rutherford Cancer Centre South Wales offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 1956, the accredited hospital is situated in Wales, United Kingdom, with 89 beds, serving local and international patients.
Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.
The London Clinic provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in , the JCI accredited hospital is based in London, United Kingdom, with 234 beds and services for domestic and international patients.
The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.
With advanced haematology and oncology infrastructure, Farrer Park Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2016, the accredited hospital is located in Singapore, Singapore, and has 220 beds.
For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.
Hospital Quironsalud Barcelona offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 1944, the JCI, ISO accredited hospital is situated in Barcelona, Spain, with 165 beds, serving local and international patients.
Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.
With advanced haematology and oncology infrastructure, Special Neolife Medical Center offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2010, the JCI accredited hospital is located in Istanbul, Turkey, and it has adequate bed capacity.
For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.
Burjeel Specialty Hospital, Sharjah provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 2019, the JCI accredited hospital is based in Sharjah, United Arab Emirates, with 75 beds and services for domestic and international patients.
The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.
Arab Medical Center offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 1997, the JCI accredited hospital is located in Amman, Jordan, with 243 beds, providing comprehensive care for local and international patients.
Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.
Ara Damansara Medical Centre offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2012, the JCI, MSQH accredited hospital is located in Kuala Lumpur, Malaysia, with 220 beds, providing comprehensive care for local and international patients.
Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.
With advanced haematology and oncology infrastructure, Medeor Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2007, the NABH, NABL accredited hospital is located in Delhi, India, and has 100 beds.
For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.
Fortis Hospital, Mulund offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 2002, the JCI, NABH accredited hospital is situated in Mumbai, India, with 315 beds, serving local and international patients.
Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.
At Manipal Hospital, Hebbal, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1991, the NABL, NABH accredited hospital is located in Bangalore, India, and has 280 beds.
Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.
Bayindir Healthcare Group provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1992, the JCI accredited hospital is based in Ankara, Turkey, with 153 beds and services for domestic and international patients.
The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.
